论文部分内容阅读
通过对文献资料的系统回顾分析,对IVF中应用hMG和FSH的结果进行了比较。 结果表明FSH治疗组明显占优势。反映临床妊娠率的三项指标即每开始周期、回收卵子、配子移植,FSH组的变异率分别为1.17～6.33;1.07～6.33;1.07～6.33;而通常的变异率和95％的可信限分别为:1.69,1.10～12.59,P=0.13;1.69,1.10～2.59,P=0.016;1.70,1.10～2.62,P=0.016。这三项指标,FSH组要高出hMG组至少50％,该结果
Through systematic review of the literature, the results of applying hMG and FSH in IVF were compared. The results showed that FSH treatment group was clearly dominant. The three indexes that reflect the clinical pregnancy rate, ie, the recovery cycle and eggplant transplantation, the mutation rates of FSH group were 1.17 ~ 6.33, 1.07 ~ 6.33 and 1.07 ~ 6.33, respectively; while the common mutation rate and 95% confidence limit Respectively: 1.69,1.10 ~ 12.59, P = 0.13; 1.69,1.10 ~ 2.59, P = 0.016; 1.70,1.10 ~ 2.62, P = 0.016. These three indicators, FSH group was higher than the hMG group by at least 50%, the result